 Tazim Dowlut-McElroy
Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Turner Syndrome | 10 | 2024 | 12 | 6.260 |
Why?
| | Menorrhagia | 3 | 2024 | 4 | 2.190 |
Why?
| | Ovarian Neoplasms | 3 | 2024 | 140 | 2.180 |
Why?
| | Gonadoblastoma | 4 | 2024 | 5 | 1.960 |
Why?
| | Female | 23 | 2024 | 4112 | 1.620 |
Why?
| | Dysgerminoma | 2 | 2024 | 3 | 1.610 |
Why?
| | Chromosomes, Human, Y | 3 | 2024 | 12 | 1.370 |
Why?
| | Adolescent | 15 | 2024 | 2570 | 1.370 |
Why?
| | Humans | 25 | 2024 | 7929 | 1.360 |
Why?
| | Mosaicism | 2 | 2024 | 16 | 1.130 |
Why?
| | Child | 17 | 2024 | 3887 | 1.080 |
Why?
| | Gynecology | 2 | 2024 | 6 | 1.010 |
Why?
| | Young Adult | 7 | 2024 | 774 | 0.990 |
Why?
| | von Willebrand Diseases | 2 | 2022 | 4 | 0.930 |
Why?
| | Ehlers-Danlos Syndrome | 1 | 2024 | 7 | 0.890 |
Why?
| | Joint Instability | 1 | 2024 | 7 | 0.890 |
Why?
| | Vulvodynia | 1 | 2023 | 1 | 0.860 |
Why?
| | Botulinum Toxins | 1 | 2023 | 8 | 0.850 |
Why?
| | Vulvar Diseases | 2 | 2023 | 3 | 0.850 |
Why?
| | Retrospective Studies | 8 | 2024 | 1455 | 0.820 |
Why?
| | Blood Platelet Disorders | 1 | 2022 | 1 | 0.810 |
Why?
| | Postpartum Hemorrhage | 1 | 2022 | 1 | 0.810 |
Why?
| | Chromosome Disorders | 1 | 2022 | 7 | 0.810 |
Why?
| | Menstruation Disturbances | 2 | 2019 | 2 | 0.790 |
Why?
| | Primary Ovarian Insufficiency | 1 | 2022 | 4 | 0.790 |
Why?
| | Graft vs Host Disease | 1 | 2022 | 17 | 0.790 |
Why?
| | Infertility | 1 | 2022 | 5 | 0.790 |
Why?
| | Fertility Preservation | 1 | 2022 | 7 | 0.780 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2022 | 59 | 0.740 |
Why?
| | Stevens-Johnson Syndrome | 1 | 2021 | 14 | 0.730 |
Why?
| | Pregnancy | 4 | 2022 | 246 | 0.690 |
Why?
| | Hymen | 1 | 2019 | 1 | 0.650 |
Why?
| | Colpotomy | 1 | 2019 | 1 | 0.650 |
Why?
| | Estrogens | 1 | 2018 | 4 | 0.630 |
Why?
| | Tissue Adhesions | 1 | 2018 | 8 | 0.620 |
Why?
| | Endometriosis | 1 | 2017 | 4 | 0.580 |
Why?
| | Operating Rooms | 1 | 2017 | 5 | 0.570 |
Why?
| | Genitalia | 1 | 2017 | 5 | 0.570 |
Why?
| | Infant | 6 | 2024 | 1683 | 0.570 |
Why?
| | Quality of Life | 3 | 2024 | 187 | 0.570 |
Why?
| | Postoperative Complications | 1 | 2019 | 193 | 0.570 |
Why?
| | Child, Preschool | 6 | 2024 | 1860 | 0.560 |
Why?
| | Wounds and Injuries | 1 | 2017 | 37 | 0.550 |
Why?
| | Emergency Service, Hospital | 1 | 2017 | 157 | 0.500 |
Why?
| | Infant, Newborn | 4 | 2024 | 966 | 0.500 |
Why?
| | Menstruation | 1 | 2015 | 4 | 0.490 |
Why?
| | Blood Coagulation Disorders | 1 | 2015 | 10 | 0.480 |
Why?
| | Castration | 3 | 2024 | 3 | 0.420 |
Why?
| | Adult | 3 | 2024 | 1359 | 0.360 |
Why?
| | Prevalence | 2 | 2024 | 179 | 0.340 |
Why?
| | Treatment Outcome | 2 | 2023 | 675 | 0.310 |
Why?
| | Dermatology | 2 | 2024 | 3 | 0.280 |
Why?
| | Vulvar Lichen Sclerosus | 2 | 2024 | 3 | 0.280 |
Why?
| | Lichen Sclerosus et Atrophicus | 2 | 2024 | 3 | 0.280 |
Why?
| | Anti-Mullerian Hormone | 2 | 2023 | 3 | 0.250 |
Why?
| | Ovary | 1 | 2024 | 8 | 0.230 |
Why?
| | Vitiligo | 1 | 2023 | 1 | 0.220 |
Why?
| | Vulvitis | 1 | 2023 | 1 | 0.220 |
Why?
| | Hormone Replacement Therapy | 1 | 2023 | 5 | 0.210 |
Why?
| | Registries | 1 | 2023 | 97 | 0.210 |
Why?
| | Estradiol | 1 | 2023 | 10 | 0.210 |
Why?
| | Delivery of Health Care | 1 | 2023 | 43 | 0.210 |
Why?
| | Patient Acceptance of Health Care | 1 | 2023 | 42 | 0.210 |
Why?
| | Practice Patterns, Physicians' | 1 | 2024 | 106 | 0.210 |
Why?
| | Sex Chromosome Aberrations | 1 | 2022 | 7 | 0.200 |
Why?
| | Prenatal Diagnosis | 1 | 2022 | 17 | 0.200 |
Why?
| | HLA Antigens | 1 | 2022 | 15 | 0.200 |
Why?
| | Placenta | 1 | 2022 | 24 | 0.200 |
Why?
| | Homosexuality, Female | 1 | 2022 | 1 | 0.200 |
Why?
| | Ovarian Reserve | 1 | 2022 | 1 | 0.200 |
Why?
| | Fertility | 1 | 2022 | 19 | 0.200 |
Why?
| | Incidence | 1 | 2022 | 145 | 0.190 |
Why?
| | Cryptorchidism | 1 | 2022 | 16 | 0.190 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2021 | 13 | 0.190 |
Why?
| | Male | 3 | 2024 | 3913 | 0.180 |
Why?
| | Suture Techniques | 1 | 2019 | 10 | 0.160 |
Why?
| | Congenital Abnormalities | 1 | 2019 | 19 | 0.160 |
Why?
| | Postoperative Care | 1 | 2019 | 31 | 0.160 |
Why?
| | Emollients | 1 | 2018 | 2 | 0.160 |
Why?
| | Administration, Topical | 1 | 2018 | 5 | 0.160 |
Why?
| | Recurrence | 1 | 2018 | 114 | 0.150 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2017 | 1 | 0.150 |
Why?
| | Pelvic Pain | 1 | 2017 | 1 | 0.150 |
Why?
| | Contraceptives, Oral | 1 | 2017 | 3 | 0.150 |
Why?
| | Severity of Illness Index | 1 | 2018 | 185 | 0.150 |
Why?
| | Cross-Sectional Studies | 3 | 2024 | 397 | 0.140 |
Why?
| | Factor VII Deficiency | 1 | 2017 | 3 | 0.140 |
Why?
| | Genitalia, Female | 1 | 2017 | 4 | 0.140 |
Why?
| | Cohort Studies | 1 | 2017 | 335 | 0.130 |
Why?
| | Hormones | 1 | 2015 | 4 | 0.120 |
Why?
| | Menarche | 1 | 2015 | 4 | 0.120 |
Why?
| | Hospitals, Pediatric | 1 | 2017 | 233 | 0.120 |
Why?
| | Laparoscopy | 1 | 2017 | 191 | 0.120 |
Why?
| | Puberty | 2 | 2024 | 8 | 0.110 |
Why?
| | Practice Guidelines as Topic | 2 | 2024 | 122 | 0.110 |
Why?
| | Hysterosalpingography | 1 | 2024 | 1 | 0.060 |
Why?
| | Neoplasms, Gonadal Tissue | 1 | 2024 | 1 | 0.060 |
Why?
| | Europe | 1 | 2024 | 39 | 0.060 |
Why?
| | Gonadotropins | 1 | 2023 | 5 | 0.060 |
Why?
| | Surveys and Questionnaires | 1 | 2024 | 341 | 0.050 |
Why?
| | Sexual Maturation | 1 | 2022 | 2 | 0.050 |
Why?
| | Gonads | 1 | 2022 | 3 | 0.050 |
Why?
| | Contraceptive Agents | 1 | 2022 | 15 | 0.050 |
Why?
| | Sexual Behavior | 1 | 2022 | 46 | 0.050 |
Why?
| | Prospective Studies | 1 | 2023 | 574 | 0.050 |
Why?
| | Child Development | 1 | 2022 | 52 | 0.050 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|